Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice
Purpose. The purpose of this study was to evaluate 2-year visual outcomes in patients with diabetic macular edema (DME) treated with anti-VEGF agents in a routine clinical setting. Methods. The medical records of patients treated with ranibizumab or aflibercept due to DME at the Eye Hospital, Univer...
Saved in:
| Main Authors: | Mojca Urbančič, Pia Klobučar, Matej Zupan, Katja Urbančič, Alenka Lavrič |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2020/6979758 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-VEGF for the Management of Diabetic Macular Edema
by: Francisco Rosa Stefanini, et al.
Published: (2014-01-01) -
Anti-VEGF agents in the treatment of diabetic macular edema
by: Vladimir Iosifovich Konenkov, et al.
Published: (2013-12-01) -
One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population
by: Guillermo Salcedo-Villanueva, et al.
Published: (2025-08-01) -
Metabolomics analysis uncovers metabolic changes and remodeling of anti-VEGF therapy on macular edema
by: Congcong Yan, et al.
Published: (2025-07-01) -
Application of deep learning algorithm for judicious use of anti-VEGF in diabetic macular edema
by: Anwesa Mondal, et al.
Published: (2025-02-01)